Subject to Regulatory Approvals, This Agreement Will Give Selected Generic Manufacturers ... - Latest Tweet by World Health Organization
The latest Tweet by World Health Organization states, 'Subject to regulatory approvals, this agreement will give selected generic manufacturers the opportunity to develop, manufacture & supply generic versions of CAB-LA, in 90 low- & middle-income countries. It's a 🔑 step to support long-term access to this #HIV prevention option.'
Subject to regulatory approvals, this agreement will give selected generic manufacturers the opportunity to develop, manufacture & supply generic versions of CAB-LA, in 90 low- & middle-income countries. It's a 🔑 step to support long-term access to this #HIV prevention option. pic.twitter.com/SqRbRus1Vf— World Health Organization (WHO) (@WHO) July 29, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)
(The above story first appeared on LatestLY on Jul 29, 2022 03:21 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
